- Home
- MAG vs NVAX Comparison
MAG vs NVAX Comparison
Compare MAG & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAG
- NVAX
- Stock Information
- Founded
- MAG N/A
- NVAX 1987
- Country
- MAG Canada
- NVAX United States
- Employees
- MAG N/A
- NVAX N/A
- Industry
- MAG Precious Metals
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAG Basic Materials
- NVAX Health Care
- Exchange
- MAG Nasdaq
- NVAX Nasdaq
- Market Cap
- MAG 1.8B
- NVAX 2.0B
- IPO Year
- MAG N/A
- NVAX 1995
- Fundamental
- Price
- MAG $13.82
- NVAX $8.70
- Analyst Decision
- MAG Strong Buy
- NVAX Buy
- Analyst Count
- MAG 4
- NVAX 6
- Target Price
- MAG $18.38
- NVAX $17.83
- AVG Volume (30 Days)
- MAG 532.2K
- NVAX 3.8M
- Earning Date
- MAG 11-12-2024
- NVAX 11-12-2024
- Dividend Yield
- MAG N/A
- NVAX N/A
- EPS Growth
- MAG 129.68
- NVAX N/A
- EPS
- MAG 0.72
- NVAX N/A
- Revenue
- MAG N/A
- NVAX $885,193,000.00
- Revenue This Year
- MAG N/A
- NVAX N/A
- Revenue Next Year
- MAG N/A
- NVAX N/A
- P/E Ratio
- MAG $19.17
- NVAX N/A
- Revenue Growth
- MAG N/A
- NVAX N/A
- 52 Week Low
- MAG $8.20
- NVAX $3.53
- 52 Week High
- MAG $18.27
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- MAG 32.74
- NVAX 46.62
- Support Level
- MAG $13.62
- NVAX $8.50
- Resistance Level
- MAG $16.19
- NVAX $9.75
- Average True Range (ATR)
- MAG 0.54
- NVAX 0.50
- MACD
- MAG -0.17
- NVAX 0.06
- Stochastic Oscillator
- MAG 7.58
- NVAX 35.19
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which achieved commercial production of around 4,000 tonnes per day. The company has also Interest in the Larder project. Also, MAG has an expanded exploration program targeting multiple prospective targets at both Juanicipio and the Deer Trail 100% earn-in project in Utah. The Juanicipio Mine recognizes revenue for silver, gold, lead, and zinc from concentrate sales.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.